Loading the section
The price of Veradermics, Incorporated (MANE) on October 9, 2026 is 130.90 USD, +3.37% on the day. Over 52 weeks the stock traded between 32.00 USD and 136.72 USD; the price now sits 94% of the way up that range. Market capitalization is 78.42 million USD, rank 227 among 374 stocks of the same industry with a known capitalization.
Closing prices for 09 October 2026
Next earnings report: none scheduled in the next five weeks · Earnings calendar
Veradermics, Incorporated trades on NYSE under the ticker MANE. The company belongs to the Health care sector. The trading history on this page starts on 04 February 2026.
Over the past 52 weeks MANE has traded between 32.00 $ and 136.72 $. As of 09 October 2026 the price stood 94.44 % of the way from the 52-week low to the high.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 0.2, below the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
MANE has a return on equity of −21.71 %, above the sector median of −41.68 %. Return on assets is −21.35 %, above the sector median of −32.11 %.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 125.71 | 135.12 | 123.02 | 130.90 | 1M |
| 08 October 2026 | 111.60 | 136.72 | 110.56 | 126.63 | 3M |
| 07 October 2026 | 108.92 | 113.43 | 108.84 | 110.95 | 655,100 |
| 06 October 2026 | 119.29 | 119.29 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Veradermics, Incorporated (MANE) is a public company in the healthcare sector. Its common stock trade on NYSE.
Over the trailing twelve months as reported to 2025-12-31, net income was -70.0m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:470 JAMES STREET, NEW HAVEN, CT, 06513, US
| 1.2B |
| PFEPfizer, Inc. | 28.18 | +1.28 % | 929M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 108.77 |
| 108.96 |
| 736,500 |
| 05 October 2026 | 116.45 | 119.12 | 114.80 | 118.87 | 536,200 |
| 02 October 2026 | 120.26 | 120.85 | 115.48 | 116.76 | 598,300 |
| 01 October 2026 | 121.23 | 123.83 | 116.04 | 117.22 | 659,800 |
| 30 September 2026 | 117.56 | 122.44 | 116.76 | 121.23 | 689,400 |
| 29 September 2026 | 115.34 | 118.94 | 112.03 | 117.82 | 481,700 |
| 28 September 2026 | 114.57 | 118.00 | 112.30 | 115.00 | 633,500 |
| 25 September 2026 | 116.00 | 118.15 | 113.88 | 116.57 | 613,600 |
| 24 September 2026 | 115.29 | 117.91 | 111.51 | 115.72 | 580,700 |
| 23 September 2026 | 118.11 | 118.74 | 110.60 | 115.78 | 753,800 |
| 22 September 2026 | 113.99 | 122.00 | 113.22 | 118.14 | 2M |
| 21 September 2026 | 107.44 | 113.24 | 105.40 | 112.80 | 583,600 |
| 18 September 2026 | 109.30 | 109.30 | 104.54 | 106.75 | 2M |
| 17 September 2026 | 105.56 | 109.74 | 102.83 | 108.68 | 766,500 |
| 16 September 2026 | 103.86 | 104.93 | 100.50 | 102.42 | 860,200 |
| 15 September 2026 | 102.02 | 105.26 | 100.01 | 103.89 | 938,800 |
| 14 September 2026 | 99.31 | 104.19 | 98.46 | 101.70 | 620,700 |